THE PHARMACOLOGICAL TOOLMAKERS RATIONAL APPROACH TO DRUG DESIGN - AN APPRECIATION OF SIR BLACK,JAMES

被引：1
作者：
GERSKOWITCH, VP
HULL, RAD
SHANKLEY, NP
机构：
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 1988年 / 9卷 / 12期
关键词：
D O I：
10.1016/0165-6147(88)90132-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：435 / 437
页数：3
相关论文
共 50 条
  • [31] Rational utilization of 1,2,3-triazole scaffold in anti-MRSA drug development: Design strategies, structural insights and pharmacological outcomes
    Singh, Atamjit
    Singh, Karanvir
    Sharma, Aman
    Kaur, Jasleen
    Kaur, Ramanpreet
    Kaur, Jashandeep
    Kaur, Kirandeep
    Chadha, Renu
    Bedi, Preet Mohinder Singh
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2024, 1295
  • [32] IDEALIZED APPROACH TO OPTIMAL DESIGN, DEVELOPMENT AND EVALUATION OF DRUG DELIVERY SYSTEMS .1. DRUG BIOAVAILABILITY INPUT-PHARMACOLOGICAL RESPONSE OUTPUT RELATIONSHIPS
    SMOLEN, VF
    KUEHN, PB
    WILLIAMS, EJ
    [J]. DRUG DEVELOPMENT COMMUNICATIONS, 1975, 1 (02): : 143 - 172
  • [33] Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design
    Misra, Pragya
    Khaliq, Tanvir
    Dixit, Anshuman
    SenGupta, Souvik
    Samant, Mukesh
    Kumari, Shraddha
    Kumar, Awanish
    Kushawaha, Pramod K.
    Majumder, H. K.
    Saxena, Anil K.
    Narender, T.
    Dube, Anuradha
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 998 - 1002
  • [34] STRUCTURAL SIMILARITY BETWEEN BINDING-SITES IN INFLUENZA SIALIDASE AND ISOCITRATE DEHYDROGENASE - IMPLICATIONS FOR AN ALTERNATIVE APPROACH TO RATIONAL DRUG DESIGN
    POIRRETTE, AR
    ARTYMIUK, PJ
    GRINDLEY, HM
    RICE, DW
    WILLETT, P
    [J]. PROTEIN SCIENCE, 1994, 3 (07) : 1128 - 1130
  • [35] 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design
    Sisir Nandi
    Manish C. Bagchi
    [J]. Molecular Diversity, 2010, 14 : 27 - 38
  • [36] 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design
    Nandi, Sisir
    Bagchi, Manish C.
    [J]. MOLECULAR DIVERSITY, 2010, 14 (01) : 27 - 38
  • [37] Discovery of Schaeffer's Acid Analogues as Lead Structures of Mycobacterium tuberculosis Type II Dehydroquinase Using a Rational Drug Design Approach
    Schmidt, Marco F.
    Korb, Oliver
    Howard, Nigel I.
    Dias, Marcio V. B.
    Blundell, Tom L.
    Abell, Chris
    [J]. CHEMMEDCHEM, 2013, 8 (01) : 54 - 58
  • [38] The high-resolution X-ray structure of vinca-domain inhibitors of microtubules provides a rational approach for drug design
    Chengyong, Wu
    Jinghong, Xian
    Yanyan, Wang
    Qing-Jie, Xiao
    Lingling, Ma
    Yuyan, Li
    Hai, Chen
    Qian, Lei
    Quan, Zhang
    Bo, Sun
    Yuxi, Wang
    [J]. FEBS LETTERS, 2021, 595 (02) : 195 - 205
  • [39] A comparative QSAR analysis and molecular docking studies of quinazoline derivatives as tyrosine kinase (EGFR) inhibitors: A rational approach to anticancer drug design
    Noolvi, Malleshappa N.
    Patel, Harun M.
    [J]. JOURNAL OF SAUDI CHEMICAL SOCIETY, 2013, 17 (04) : 361 - 379
  • [40] Three-dimensional structure of heat shock protein 90 from Plasmodium falciparum: molecular modelling approach to rational drug design against malaria
    Ranjit Kumar
    Soundara Raghavan Pavithra
    Utpal Tatu
    [J]. Journal of Biosciences, 2007, 32 : 531 - 536
12345